CytoDyn Inc.
CYDY
$0.35
$0.038.84%
OTC PK
| 02/28/2026 | 11/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -8.06% | 5.02% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 23.56% | 3.15% | |||
| Operating Income | -23.56% | -3.15% | |||
| Income Before Tax | 79.25% | -308.07% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 79.25% | -308.07% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 79.25% | -308.07% | |||
| EBIT | -23.56% | -3.15% | |||
| EBITDA | -23.61% | -3.14% | |||
| EPS Basic | 78.02% | -287.23% | |||
| Normalized Basic EPS | -40.00% | -7.14% | |||
| EPS Diluted | 80.00% | -325.53% | |||
| Normalized Diluted EPS | -40.00% | -7.14% | |||
| Average Basic Shares Outstanding | 1.12% | 0.68% | |||
| Average Diluted Shares Outstanding | 1.12% | 0.68% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||